Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
Current Oncology Reports
|
October 19, 2023
Advances in Treatment of Waldenström Macroglobulinemia
Eric Durot, Cécile Tomowiak
Blood
|
August 31, 2011
Blood consult: high Sokal risk chronic myeloid leukemia and suboptimal response
Lydia Roy, Cécile Tomowiak, François Guilhot
Current Opinion in Hematology
|
January 10, 2012
Current treatment strategies in chronic myeloid leukemia
François Guilhot, Lydia Roy, Cécile Tomowiak
Hematology/Oncology Clinics of North America
|
September 8, 2018
Working Toward a Genomic Prognostic Classification of Waldenström Macroglobulinemia: C-X-C Chemokine Receptor Type 4 Mutation and Beyond
Marion Magierowicz, Cécile Tomowiak, Xavier Leleu, et al.
Presse Medicale (Paris, France : 1983)
|
August 25, 2019
[Waldenström macroglobulinaemia]
Cécile Tomowiak, Stéphanie Poulain, Céline Debiais, et al.
Frontiers in Pharmacology
|
November 15, 2021
Safety Profile of Ibrutinib: An Analysis of the WHO Pharmacovigilance Database
Marion Allouchery, Cécile Tomowiak, Thomas Lombard, et al.
Bulletin Du Cancer
|
December 22, 2024
[Updates on hairy cell leukemia (HCL) and HCL-like disorders]
Xavier Troussard, Elsa Maitre, Urbain Tauveron-Jalenques, et al.
Acta Haematologica
|
January 19, 2013
Failure of fluorodeoxyglucose positron emission tomography to detect the high-grade transformation of nodular lymphocyte predominant Hodgkin's lymphoma
Mathieu Puyade, Mokrane Yacoub, Cécile Tomowiak, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 15, 2024
Expert Opinion on Managing Adverse Reactions Associated With Acalabrutinib Therapy: A Delphi Consensus From France
Loïc Ysebaert, Stéphane Ederhy, Véronique Leblond, et al.
Hematology/Oncology Clinics of North America
|
May 28, 2023
Evaluation and Management of Disease Transformation in Waldenström Macroglobulinemia
Dipti Talaulikar, Cécile Tomowiak, Elise Toussaint, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
Current Oncology Reports
|
October 19, 2023
Advances in Treatment of Waldenström Macroglobulinemia
Eric Durot, Cécile Tomowiak
Blood
|
August 31, 2011
Blood consult: high Sokal risk chronic myeloid leukemia and suboptimal response
Lydia Roy, Cécile Tomowiak, François Guilhot
Current Opinion in Hematology
|
January 10, 2012
Current treatment strategies in chronic myeloid leukemia
François Guilhot, Lydia Roy, Cécile Tomowiak
Hematology/Oncology Clinics of North America
|
September 8, 2018
Working Toward a Genomic Prognostic Classification of Waldenström Macroglobulinemia: C-X-C Chemokine Receptor Type 4 Mutation and Beyond
Marion Magierowicz, Cécile Tomowiak, Xavier Leleu, et al.
Presse Medicale (Paris, France : 1983)
|
August 25, 2019
[Waldenström macroglobulinaemia]
Cécile Tomowiak, Stéphanie Poulain, Céline Debiais, et al.
Frontiers in Pharmacology
|
November 15, 2021
Safety Profile of Ibrutinib: An Analysis of the WHO Pharmacovigilance Database
Marion Allouchery, Cécile Tomowiak, Thomas Lombard, et al.
Bulletin Du Cancer
|
December 22, 2024
[Updates on hairy cell leukemia (HCL) and HCL-like disorders]
Xavier Troussard, Elsa Maitre, Urbain Tauveron-Jalenques, et al.
Acta Haematologica
|
January 19, 2013
Failure of fluorodeoxyglucose positron emission tomography to detect the high-grade transformation of nodular lymphocyte predominant Hodgkin's lymphoma
Mathieu Puyade, Mokrane Yacoub, Cécile Tomowiak, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 15, 2024
Expert Opinion on Managing Adverse Reactions Associated With Acalabrutinib Therapy: A Delphi Consensus From France
Loïc Ysebaert, Stéphane Ederhy, Véronique Leblond, et al.
Hematology/Oncology Clinics of North America
|
May 28, 2023
Evaluation and Management of Disease Transformation in Waldenström Macroglobulinemia
Dipti Talaulikar, Cécile Tomowiak, Elise Toussaint, et al.
Page
of 6